This letter to the editor responds to comments in the still open debate regarding the use of breakthrough pain medications in cancer patients.
CITATION STYLE
Mercadante, S. (2020). The Endless Question of Opioid Doses for Breakthrough Pain. The Oncologist, 25(7), e1134–e1135. https://doi.org/10.1634/theoncologist.2020-0312
Mendeley helps you to discover research relevant for your work.